Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00124527
Status:
COMPLETED
Last Update Posted:
2021-06-16
First Post:
2005-07-26
Brief Title:
Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer
Sponsor:
Eisai Inc
Organization:
Eisai Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Thyroid Cancer |
Keywords:
| Name | View |
|---|---|
| Irofulven Thyroid Cancer | View |